Skip to main content
Federal Circuit· 7/12/1996

Merck & Co., Inc. v. Kessler

Citations

  • 80 F.3d 1543

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • concluding for product patents that “the restoration period of the patent does not extend to all products protected by the patent but only to the product on which the extension was based”
  • “The statute contemplates a patentee receiving time lost in its patent term by reason of FDA delay, and the statute should be liberally interpreted to achieve this end.”
  • “Prior to June 8, 1995, U.S. patents had an expiration date under 35 U.S.C. § 154 measured as 17 years from the date the patent issued, except where terminal disclaimers were filed.”
  • no deference to Patent & Trademark Office on substantive patent law issues

Source: CourtListener parenthetical corpus (CC0).

Read full opinion on CourtListener

Cited by

27 cases in this archive cite this case; the 20 most cited are listed.

Cites

15 cases in this archive are cited by this case.

Other cases named Merck & Co., Inc. v. Kessler

1 other CourtListener record shares this case name.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.